When it comes to deadly viruses, what's in a name?
For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of names. Full Article
REUTERS SHOWCASE
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Watson launches generic of ViroPharma's antibiotic
 |
Aishwarya at Cannes
Aishwarya Rai Bachchan marks 12 years at the Cannes Film Festival. Here is how she looked over the years. Slideshow
(Reuters) - Generic drugmaker Watson Pharmaceuticals Inc said U.S. health regulators approved its copycat version of ViroPharma Inc's antibiotic Vancocin.
Separately, ViroPharma said the U.S. Food and Drug Administration declined its citizen petition, which was filed to prevent Watson from launching the generic version.
Shares of ViroPharma were trading down 18 percent at $23.40 in premarket.
Watson said it has started shipping the drug, which recorded sales of $332 million for the 12 months ended February 29, 2012.
ViroPharma shares closed at $28.61 on Monday on the Nasdaq.
(Reporting by Anand Basu in Bangalore; Editing by Sriraj Kalluvila)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters